AI
| Followers | 48 |
| Posts | 12087 |
| Boards Moderated | 0 |
| Alias Born | 09/12/2017 |
Saturday, August 07, 2021 3:51:27 PM
Ahh yes, title of PR gives the inclination P3 is granted a go-
CytoDyn Receives Clearance from Brazil’s ANVISA to Commence Phase 3 Trial for Severe COVID-19 Patients
But but but but right below the title it says-
Expects to Conduct Interim Analysis After Completion of 40% of the Enrollment
Then in the first paragraph admits-
has approved the previously submitted clinical trial protocol to commence patient enrollment in its CD17 trial for severe COVID-19 patients.
https://finance.yahoo.com/news/cytodyn-receives-clearance-brazil-anvisa-100000047.html
Title was enough to convince CYDY loyalists that ANVISA authorized injections.
CytoDyn Receives Clearance from Brazil’s ANVISA to Commence Phase 3 Trial for Severe COVID-19 Patients
But but but but right below the title it says-
Expects to Conduct Interim Analysis After Completion of 40% of the Enrollment
Then in the first paragraph admits-
has approved the previously submitted clinical trial protocol to commence patient enrollment in its CD17 trial for severe COVID-19 patients.
https://finance.yahoo.com/news/cytodyn-receives-clearance-brazil-anvisa-100000047.html
Title was enough to convince CYDY loyalists that ANVISA authorized injections.
